Total Payments
$5,700
2024 Payments
$1,683
Companies
41
Transactions
334
Medicare Patients
2,339
Medicare Billing
$395,001
Payment Breakdown by Category
Food & Beverage$5,641 (99.0%)
Gifts$59.40 (1.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,641 | 333 | 99.0% |
| Gift | $59.40 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $768.26 | 49 | $0 (2024) |
| ABBVIE INC. | $541.86 | 36 | $0 (2024) |
| Lilly USA, LLC | $495.94 | 33 | $0 (2024) |
| Amgen Inc. | $492.40 | 34 | $0 (2024) |
| GlaxoSmithKline, LLC. | $416.17 | 21 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $287.48 | 14 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $265.86 | 15 | $0 (2024) |
| Merck Sharp & Dohme LLC | $245.80 | 15 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $230.15 | 12 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $213.03 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,683 | 101 | Novo Nordisk Inc ($315.63) |
| 2023 | $1,881 | 107 | Novo Nordisk Inc ($255.58) |
| 2022 | $1,719 | 101 | ABBVIE INC. ($193.35) |
| 2021 | $416.88 | 25 | Amgen Inc. ($87.95) |
All Payment Transactions
334 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: Neurology | ||||||
| 12/16/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Endocrinology | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Biological | ||||||
| 11/07/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $3.29 | General |
| Category: Inflammation | ||||||
| 10/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Inflammation | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Endocrinology | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Biological | ||||||
| 10/07/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.08 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $29.39 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $2.03 | General |
| Category: Inflammation | ||||||
| 09/18/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,636 | 3,416 | $500,295 | $274,726 |
| 2022 | 10 | 703 | 1,129 | $195,713 | $120,275 |
Total Patients
2,339
Total Services
4,545
Medicare Billing
$395,001
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 454 | 1,496 | $237,864 | $137,105 | 57.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 239 | 239 | $38,001 | $29,799 | 78.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 201 | 201 | $48,441 | $21,811 | 45.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 68 | 456 | $29,640 | $21,666 | 73.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 52 | 162 | $33,696 | $15,132 | 44.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 61 | 74 | $22,940 | $13,728 | 59.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 53 | 64 | $24,366 | $8,681 | 35.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 39 | 43 | $9,030 | $5,795 | 64.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 52 | 64 | $16,064 | $5,786 | 36.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 35 | 46 | $9,048 | $2,880 | 31.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 34 | 34 | $3,400 | $2,578 | 75.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 92 | 185 | $6,660 | $1,761 | 26.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 34 | 38 | $4,560 | $1,532 | 33.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 23 | $2,254 | $1,487 | 66.0% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 26 | 30 | $2,355 | $1,051 | 44.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 35 | 35 | $1,105 | $1,038 | 94.0% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 14 | 28 | $2,520 | $863.46 | 34.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 12 | 16 | $1,888 | $791.89 | 41.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 47 | $1,410 | $501.40 | 35.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 43 | 47 | $3,243 | $482.46 | 14.9% |
| 93042 | Electrocardiogram (ecg) 1 to 3 leads with review by physician only | Facility | 2023 | 18 | 31 | $930.00 | $166.47 | 17.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 22 | 31 | $620.00 | $68.20 | 11.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 15 | 26 | $260.00 | $22.75 | 8.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 260 | 664 | $105,576 | $64,703 | 61.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 131 | 131 | $31,571 | $16,381 | 51.9% |
About Dr. Nicholas Steckler, DO
Dr. Nicholas Steckler, DO is a Internal Medicine healthcare provider based in Niceville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2018. The National Provider Identifier (NPI) number assigned to this provider is 1801386578.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nicholas Steckler, DO has received a total of $5,700 in payments from pharmaceutical and medical device companies, with $1,683 received in 2024. These payments were reported across 334 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($5,641).
As a Medicare-enrolled provider, Steckler has provided services to 2,339 Medicare beneficiaries, totaling 4,545 services with total Medicare billing of $395,001. Data is available for 2 years (2022–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Niceville, FL
- Active Since 05/17/2018
- Last Updated 09/17/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1801386578
Products in Payments
- Ozempic (Drug) $518.84
- TRELEGY ELLIPTA (Drug) $416.17
- VRAYLAR (Drug) $333.56
- MOUNJARO (Drug) $325.02
- Kerendia (Drug) $287.48
- Otezla (Drug) $234.25
- Rybelsus (Drug) $213.54
- XARELTO (Drug) $193.81
- EVENITY (Biological) $189.63
- NURTEC ODT (Drug) $183.64
- BELSOMRA (Drug) $176.85
- UBRELVY (Drug) $158.43
- LEQVIO (Drug) $154.59
- TRINTELLIX (Drug) $148.30
- AIRSUPRA (Drug) $144.62
- FARXIGA (Drug) $121.24
- XIFAXAN (Drug) $86.78
- Kimyrsa (Drug) $86.64
- JARDIANCE (Drug) $82.82
- VYVANSE (Drug) $81.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Niceville
Garry Banks, Md Pa, MD PA
Internal Medicine — Payments: $223,037
Internal Medicine $223,037
Dr. Michael Roberts, M.d, M.D
Internal Medicine — Payments: $15,064
Internal Medicine $15,064
Dr. Michael Weisbruch, M.d, M.D
Internal Medicine — Payments: $1,606
Internal Medicine $1,606
Stephen Zimmermann, Md, MD
Internal Medicine — Payments: $911.91
Internal Medicine $911.91
Cinderella Aquino, M.d, M.D
Internal Medicine — Payments: $687.66
Internal Medicine $687.66
Mark Schroeder, M.d, M.D
Internal Medicine — Payments: $263.06
Internal Medicine $263.06